PICO Portalanswers from OpenAlex
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
PaperCitations, authors & open-access status
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Idarucizumab for Dabigatran Reversal — Full Cohort Analysis have?
PICO Portalcitation count
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis has 1,144 citations in the OpenAlex counts PICO Portal stores.
When was Idarucizumab for Dabigatran Reversal — Full Cohort Analysis published?
PICO Portalyear
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis has 2017 year in the PICO Portal index.
What is the open-access status of Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
PICO Portaloa status
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis has bronze oa status in the PICO Portal index.
What is the DOI of Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
PICO Portaldoi
The DOI for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is on the source record.
What is the PMID of Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
PICO Portalpmid
The PMID for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is on the source record.
What is the OpenAlex record for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis?
PICO Portalopenalex
The OpenAlex for Idarucizumab for Dabigatran Reversal — Full Cohort Analysis is on the source record.